A new blood test tracking immune cell aging may offer an objective way to detect depression before symptoms manifest.
SYNLAB and ALCEDIAG recently launched the first blood test to assist in mental health diagnosis in France. The test is aimed at differentiating bipolar disorders from depression. The news may be ...
PsyPost on MSN
Clinical trial suggests an anti-inflammatory drug could relieve difficult-to-treat depression
A recent clinical trial suggests that treating the immune system with an anti-inflammatory drug could relieve symptoms in ...
SALT LAKE CITY, Sept. 3, 2025 – Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six ...
Like many first-time mothers, Lisette Lopez-Rose thought childbirth would usher in a time of joy. Instead, she had panic attacks as she imagined that something bad was going to happen to her baby, and ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A world-first study has shown that it is possible to determine who is ...
The anti-inflammatory drug tocilizumab targets the IL-6 pathway to achieve a 54% remission rate in hard-to-treat depression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results